Breaking

Monday, 16 July 2018

New Zealand-based MARS bioimaging has developed world's first full-colour 3D X-ray

                  

The world's first full-colour, 3D X-ray dubbed the 'MARS scanner' has been developed by New Zealand-based MARS bioimaging, the tech uses a collection of specially developed chips which like a camera, capture each individual particle in the human body.

The project took 20 years to complete and was led by the company's founders and current chief officers Phil and Anthony Butler from the Canterbury and Otago Universities. Their scanner is "the first commercially available 3D spectral (multi-energy) scanner to produce in vivo images with anatomic and molecular quantification."

images courtesy of MARS bioimaging unless stated otherwise

The ‘medipix‘ chips work like pixel detectors, which are able to relay color information, allowing the MARS machine to formulate a 3D model of the human body. the final image produces is strikingly accurate, distinguishing between bone, cartilage, soft tissue and metal. in an example published by the company, an ankle slice through, taken by the MARS scanner shows the different colours of bone in white, and soft tissue and muscle in red.



The father and son duo behind MARS bioimaging developed the tech over a decade in collaboration with the universities of canterbury and otago. the scanning systems uses technology originally developed at CERN (the european organization for nuclear research), enhanced with custom data-processing algorithms, can detect the change in wavelengths as x-rays pass through different materials in the body.

image courtesy of medipix


According to the company, MARS bioimaging ltd plans to commercialize the scanner in the future. up until this point it has  been used to study cancer, vascular diseases that lead to strokes and heart attacks, and bone and joint health.

videos courtesy of MARS bioimaging


The project was made possible due a license agreement provided by CERN's Knowledge Transfer group. “It is always satisfying to see our work leveraging benefits for patients around the world," said Aurélie Pezous, CERN Knowledge Transfer Officer.

No comments:

Post a Comment